| Primary |
| Product Used For Unknown Indication |
30.5% |
| Drug Use For Unknown Indication |
21.1% |
| Back Pain |
9.5% |
| Pain |
8.8% |
| Depression |
3.2% |
| Femur Fracture |
2.8% |
| Gout |
2.8% |
| Hypertension |
2.8% |
| Foetal Exposure During Pregnancy |
2.5% |
| Spinal Pain |
2.5% |
| Multiple Myeloma |
2.1% |
| Ankylosing Spondylitis |
1.8% |
| Epilepsy |
1.4% |
| Fibromyalgia |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Sleep Disorder |
1.4% |
| Cardiac Failure |
1.1% |
| Cerebrovascular Accident |
1.1% |
| Convulsion |
1.1% |
| Diabetes Mellitus |
1.1% |
|
| Vomiting |
15.4% |
| Respiratory Failure |
7.7% |
| Somnolence |
7.7% |
| Drug Interaction |
5.8% |
| Palpitations |
5.8% |
| Blood Creatine Phosphokinase Increased |
3.8% |
| Feeling Abnormal |
3.8% |
| Foetal Exposure During Pregnancy |
3.8% |
| Hypersensitivity |
3.8% |
| International Normalised Ratio Increased |
3.8% |
| Overdose |
3.8% |
| Spinal Pain |
3.8% |
| Subileus |
3.8% |
| Syncope |
3.8% |
| Therapy Regimen Changed |
3.8% |
| Toxic Epidermal Necrolysis |
3.8% |
| Unresponsive To Stimuli |
3.8% |
| Urinary Retention |
3.8% |
| Weight Decreased |
3.8% |
| Withdrawal Syndrome |
3.8% |
|
| Secondary |
| Pain |
18.8% |
| Hypertension |
11.2% |
| Drug Use For Unknown Indication |
10.1% |
| Product Used For Unknown Indication |
8.2% |
| Psoas Abscess |
7.5% |
| Supplementation Therapy |
6.5% |
| Prophylaxis |
4.7% |
| Thrombosis Prophylaxis |
4.2% |
| Rheumatoid Arthritis |
3.5% |
| Hyperglycaemia |
2.8% |
| Nausea |
2.8% |
| Pyrexia |
2.8% |
| Restlessness |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Depression |
2.2% |
| Cardiac Failure |
2.1% |
| Sleep Disorder |
2.1% |
| Back Pain |
2.0% |
| Hypothyroidism |
2.0% |
| Diabetes Mellitus |
1.8% |
|
| Stevens-johnson Syndrome |
16.7% |
| Toxic Epidermal Necrolysis |
11.5% |
| Sepsis |
7.3% |
| Urinary Tract Infection |
7.3% |
| Therapy Regimen Changed |
6.3% |
| Vomiting |
6.3% |
| Somnolence |
5.2% |
| Weight Decreased |
5.2% |
| Cognitive Disorder |
4.2% |
| Stomatitis |
4.2% |
| Tachycardia |
4.2% |
| Respiratory Failure |
3.1% |
| Syncope |
3.1% |
| Withdrawal Syndrome |
3.1% |
| Cardio-respiratory Arrest |
2.1% |
| Cold Sweat |
2.1% |
| Dizziness |
2.1% |
| Nausea |
2.1% |
| Neonatal Respiratory Distress Syndrome |
2.1% |
| Pain |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.3% |
| Pain |
11.3% |
| Drug Use For Unknown Indication |
10.2% |
| Rheumatoid Arthritis |
8.2% |
| Prophylaxis |
7.4% |
| Hypertension |
7.2% |
| Osteoporosis |
1.9% |
| Depression |
1.8% |
| Crohn's Disease |
1.8% |
| Multiple Myeloma |
1.7% |
| Non-small Cell Lung Cancer |
1.7% |
| Nausea |
1.6% |
| Thrombosis Prophylaxis |
1.5% |
| Colorectal Cancer |
1.5% |
| Cancer Pain |
1.4% |
| Diabetes Mellitus |
1.4% |
| Pain Prophylaxis |
1.3% |
| Hepatic Neoplasm Malignant |
1.3% |
| Osteoarthritis |
1.3% |
| Coronary Artery Disease |
1.2% |
|
| Pyrexia |
8.4% |
| Vomiting |
7.9% |
| General Physical Health Deterioration |
6.9% |
| Sepsis |
6.9% |
| Thrombocytopenia |
6.9% |
| Colitis Ulcerative |
5.9% |
| Pneumonia |
5.4% |
| Tachycardia |
5.0% |
| Toxic Epidermal Necrolysis |
5.0% |
| Weight Increased |
5.0% |
| Death |
4.5% |
| Nausea |
4.5% |
| Aspartate Aminotransferase Increased |
3.5% |
| Osteonecrosis Of Jaw |
3.5% |
| Pain |
3.5% |
| Pain In Extremity |
3.5% |
| Renal Failure |
3.5% |
| Renal Failure Acute |
3.5% |
| Spinal Disorder |
3.5% |
| Weight Decreased |
3.5% |
|
| Interacting |
| Back Pain |
10.9% |
| Drug Use For Unknown Indication |
10.9% |
| Cardiac Failure |
7.3% |
| Cerebrovascular Accident |
7.3% |
| Epilepsy |
7.3% |
| Femur Fracture |
7.3% |
| Pain |
5.5% |
| Anxiety Disorder |
3.6% |
| Benign Prostatic Hyperplasia |
3.6% |
| Constipation |
3.6% |
| Depression |
3.6% |
| Intervertebral Disc Protrusion |
3.6% |
| Metabolic Syndrome |
3.6% |
| Muscle Spasticity |
3.6% |
| Polyneuropathy |
3.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.6% |
| Renal Impairment |
3.6% |
| Type 2 Diabetes Mellitus |
3.6% |
| Atrial Fibrillation |
1.8% |
| Restlessness |
1.8% |
|
| Depressed Level Of Consciousness |
16.7% |
| Respiratory Failure |
16.7% |
| Somnolence |
16.7% |
| Toxicity To Various Agents |
16.7% |
| Bradycardia |
8.3% |
| Electrocardiogram Qt Interval |
8.3% |
| Hypoxic-ischaemic Encephalopathy |
8.3% |
| Joint Swelling |
8.3% |
|
